Volume 81, Issue 5, Pages (May 2013)

Slides:

Advertisements

Similar presentations

Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.

Advertisements

Box and Whisker Plots Example: Comparing two samples.

Lauren B. Headrick, BS, Cassie C. Rowe, BS, Ashley R

Kamyar Kalantar-Zadeh Kidney International

Rectourethral Fistula After High-intensity Focused Ultrasound Therapy for Prostate Cancer and Its Surgical Management Christopher Netsch, Thorsten Bach,

How to Calculate Your Body Mass Index (BMI)

Volume 76, Issue 2, Pages (August 2010)

Volume 80, Issue 2, Pages (August 2012)

High Positive End-Expiratory Pressure Is Associated with Improved Survival in Obese Patients with Acute Respiratory Distress Syndrome Christian Bime,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Hematocrit Response and Risk Factors for Significant Hematocrit Elevation with Implantable Testosterone Pellets Russell P. Hayden, Nelson E. Bennett,

Colleen McKee, MS, Lisa Long, MA, Linda H

Establishment of reference intervals for sex hormone binding globulin, LC-MS/MS derived free androgen index and calculated free testosterone SN Duignan,

Volume 54, Issue 2, Pages (August 1998)

Fig. 2. Multivariable-adjusted mean serum 25-hydroxyvitamin D [25(OH)D] levels by sex and lifestyle factors (A-F). BMI, body mass index (kg/m2): underweight.

Determinants of Overweight and Obesity in Lung Transplant Recipients

Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index Suma Vupputuri, PhD, Caroline.

Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth Abraham Morgentaler, Abdulmaged.

An Evidence-based Guide for Obesity Treatment in Primary Care

Volume 189, Issue 1, Pages S26-S33 (January 2013)

An Evidence-based Guide for Obesity Treatment in Primary Care

Volume 9, Issue 8, Pages (August 2017)

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Personalized Medicine in Psychiatry

Body Mass Index and Weight Loss in Overweight and Obese Korean Women: The Mediating Role of Body Weight Perception Sunjoo Boo, RN, PhD Asian Nursing.

The Evolution of the Algorithms for Collective Behavior

Body Mass Index and Mortality in Acute Myocardial Infarction Patients

Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis Annelies Overbeek, Frank J. Broekmans, Wouter.

Body Mass Index and Operating Times in Vascular Procedures

Increased body-mass index in patients with narcolepsy

Evidence Supporting Idarucizumab for the Reversal of Dabigatran

M. Kats, A.M. Hawxby, J. Barker, M. Allon Kidney International

Body Composition and Heart Failure Prevalence and Prognosis: Getting to the Fat of the Matter in the “Obesity Paradox” Carl J. Lavie, MD, Richard V.

Volume 26, Issue 1, Pages (July 2017)

Apurva O. Badheka, MD, Ankit Rathod, MD, Mohammad A

Jessica L. Lee, MD, MS, Esther S. Oh, MD, Rebecca W. Lee, MD, Thomas E

Differential effect of weight loss on insulin resistance in surgically treated obese patients Elza Muscelli, MD, Gertrude Mingrone, MD, Stefania Camastra,

Proteomics Moves into the Fast Lane

The Obesity Paradox, Weight Loss, and Coronary Disease

Volume 54, Issue 2, Pages (August 1998)

Neal Shore European Urology Supplements

Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with.

Normalization of Protein Intake by Body Weight and the Associations of Protein Intake With Nutritional Status and Survival Srinivasan Beddhu, MD, Nirupama.

High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage Luciano G Nardo,

Molly E. Waring, PhD, Jane S

David J. Hass, Colleen M. Brensinger, James D. Lewis, Gary R

Kamyar Kalantar-Zadeh Kidney International

Volume 27, Issue 4, Pages e4 (April 2018)

Zehong Zhou, Rong Li, Jie Qiao Reproductive BioMedicine Online

Steroid hormone levels in pregnancy and 1 year postpartum using isotope dilution tandem mass spectrometry Offie P. Soldin, Ph.D., Tiedong Guo, M.Sc.,

Influences on endometrial development during intrauterine insemination: clinical experience of 2,929 patients with unexplained infertility Erin Foran.

New Trends in Managing the Prostate Cancer Patient

Volume 65, Issue 2, Pages (February 2004)

Volume 62, Issue 6, Pages (December 2002)

M. Kats, A.M. Hawxby, J. Barker, M. Allon Kidney International

Volume 63, Issue 5, Pages (May 2003)

Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer P. Mongiat-Artus, P. Teillac

Prognostic Models to Predict Survival in Non–Small-Cell Lung Cancer Patients Treated with First-Line Paclitaxel and Carboplatin with or without Bevacizumab

Does Testosterone Have a Role in Erectile Function?

Abdulla K. Salahudeen, Erwin H. Fleischmann, John D. Bower

Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating.

Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery C. Solomon,

Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D

Volume 55, Issue 4, Pages (April 1999)

Dijana Hadžiomerović, M. D. , Bernhard Rabenbauer, M. D

Effect of body mass index in acute respiratory distress syndrome

Obesity and androgens: facts and perspectives

William W. Hurd, M. D. , Lawrence S. Amesse, M. D. , Jack S. Gruber, M

Navigating the Deubiquitinating Proteome with a CompPASS

Two to 20 years: female patients, continued.

Presentation transcript:

Volume 81, Issue 5, Pages 1005-1009 (May 2013) Relationship Between Body Mass Index and Serum Testosterone Concentration in Patients Receiving Luteinizing Hormone-releasing Hormone Agonist Therapy for Prostate Cancer Tim M. van der Sluis, R. Jeroen A. van Moorselaar, Eric J.H. Meuleman, Ronald W. ter Haar, Hong N. Bui, Annemieke C. Heijboer, André N. Vis Urology Volume 81, Issue 5, Pages 1005-1009 (May 2013) DOI: 10.1016/j.urology.2013.01.014 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Box plot showing serum total testosterone levels in patients after luteinizing hormone-releasing hormone H agonist therapy measured using isotope dilution-liquid chromatography-tandem mass spectrometry as function of body mass index (BMI). Patient groups classified as normal weight (BMI <25 kg/m2), overweight (BMI 25-30 kg/m2), or obese (BMI >30 kg/m2). Upper and lower quartiles represented by rectangle; 95% confidence interval by whiskers. Differences between groups were not statistically significant. (Color version available online.) Urology 2013 81, 1005-1009DOI: (10.1016/j.urology.2013.01.014) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Box plot showing serum sex hormone-binding globulin levels in patients after luteinizing hormone-releasing hormone agonist therapy as function of body mass index (BMI). Upper and lower quartiles represented by rectangle; 95% confidence interval by whiskers. (Color version available online.) Urology 2013 81, 1005-1009DOI: (10.1016/j.urology.2013.01.014) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 Box plot showing serum free testosterone levels in patients after luteinizing hormone-releasing hormone agonist therapy, calculated using algorithm reported by Vermeulen et al19 with fixed albumin concentration of 43 g/L (P <.05 only for obese vs normal weight and overweight). (Color version available online.) Urology 2013 81, 1005-1009DOI: (10.1016/j.urology.2013.01.014) Copyright © 2013 Elsevier Inc. Terms and Conditions